Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
1.430
-0.090 (-5.92%)
Dec 26, 2025, 4:00 PM EST - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
Vaccine Discovery and Development
58.47K

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
Switzerland
58.47K